Cargando…
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
While initial approaches to adoptive T cell therapy relied on the identification and expansion of rare tumour-reactive T cells, genetic engineering has transformed cancer immunotherapy by enabling the modification of primary T cells to increase their therapeutic potential. Specifically, gene editing...
Autores principales: | Atsavapranee, Ella S., Billingsley, Margaret M., Mitchell, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099660/ https://www.ncbi.nlm.nih.gov/pubmed/33910123 http://dx.doi.org/10.1016/j.ebiom.2021.103354 |
Ejemplares similares
-
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020) -
Editing out HIV: application of gene editing technology to achieve functional cure
por: Xun, Jingna, et al.
Publicado: (2021) -
Application of Gene Editing Technology in Resistance Breeding of Livestock
por: Wang, Sutian, et al.
Publicado: (2022) -
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021) -
Genome-editing Technologies for Gene and Cell Therapy
por: Maeder, Morgan L, et al.
Publicado: (2016)